Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Digital pathology: Proscia raises $23 million for cancer diagnosis tech

Proscia
By Author Proscia | December 1, 2020

Proscia, a six-year-old Center City-based startup which says its cancer-finding Concentriq software is used by 5,000 pathologists and scientists, has raised another $23 million from investors led by California-based Scale Venture Partners and Japan-based electronics giant Hitachi Ltd.’s venture capital arm.

 

Our website uses cookies. By using this site, you agree to its use of cookies.